FCP
ISRG icon

Fidelis Capital Partners’s Intuitive Surgical ISRG Stock Holding History

Fidelis Capital Partners’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
2,799
-18
-0.6% -$9.11K 0.09% 178
2025
Q4 		$1.6M Buy
2,817
+471
+20% +$251K 0.12% 143
2025
Q3 		$1.05M Sell
2,346
-109
-4% -$52.3K 0.08% 186
2025
Q2 		$1.16M Buy
2,455
+75
+3% +$39.2K 0.11% 154
2025
Q1 		$1.22M Buy
2,380
+95
+4% +$52.5K 0.13% 132
2024
Q4 		$1.32M Buy
2,285
+9
+0.4% +$4.69K 0.13% 133
2024
Q3 		$1.17M Sell
2,276
-162
-7% -$75.4K 0.14% 130
2024
Q2 		$1.1M Buy
2,438
+123
+5% +$49K 0.16% 117
2024
Q1 		$924K Buy
2,315
+491
+27% +$186K 0.14% 139
2023
Q4 		$615K Buy
1,824
+80
+5% +$23.8K 0.14% 148
2023
Q3 		$510K Buy
1,744
+153
+10% +$47.8K 0.17% 129
2023
Q2 		$544K Buy
1,591
+60
+4% +$18.2K 0.2% 119
2023
Q1 		$467K Buy
+1,531
New +$377K 0.2% 123

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelis Capital Partners's ISRG Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Intuitive Surgical (ISRG) stake by 0.64% in Q1 2026, selling an estimated $9.11K and leaving 2,799 shares worth $1.29M. The position accounts for 0.09% of the portfolio, ranked #178.

Fidelis Capital Partners first reported a position in ISRG in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.6M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Fidelis Capital Partners held 2,799 shares of Intuitive Surgical worth $1.29M as of Q1 2026.
  • Fidelis Capital Partners sold 18 Intuitive Surgical shares in Q1 2026, an estimated $9.11K.
  • Intuitive Surgical made up 0.09% of Fidelis Capital Partners's portfolio in Q1 2026, its #178 holding.
  • Fidelis Capital Partners first reported a position in Intuitive Surgical in Q1 2023 and has held it in 13 quarters since.
  • Fidelis Capital Partners's Intuitive Surgical position peaked at $1.6M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.